Nuvectis Pharma, Inc. (NVCT) Ownership
NVCT ownership summary
as of October 18, 2026- Institutions
- 33.6% of shares outstanding
- Insiders
- 34.43% of shares outstanding
- Shares outstanding
- 32.6M
- Float
- 21.2M shares available to trade
- Short interest
- 11.62% 2.5M shares short
- Days to cover
- 12.29 short interest up 6.8% vs prior month
- Institutions 33.58%
- Insiders 34.43%
- Other investors 31.99%
NVCT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 4.80% | 1.6M | $28.8M | +1.6M (0.0%) | June 30, 2026 |
| 2 | BlackRock Inc | 3.10% | 1.0M | $18.6M | +236,844 (+31.0%) | June 30, 2026 |
| 3 | Perceptive Advisors LLC | 3.10% | 1.0M | $18.6M | +1.0M (0.0%) | June 30, 2026 |
| 4 | Soleus Capital Management, L.P. | 3.10% | 1.0M | $18.6M | +1.0M (0.0%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 2.70% | 872K | $16.2M | +212,603 (+32.2%) | June 30, 2026 |
| 6 | Iridian Asset Management LLC | 2.41% | 777K | $14.5M | +125,321 (+19.2%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 1.34% | 432K | $8.0M | +48,168 (+12.5%) | June 30, 2026 |
| 8 | Sphera Funds Management Ltd. | 1.19% | 383K | $7.1M | +382,945 (0.0%) | June 30, 2026 |
| 9 | Baldwin Brothers Inc | 1.18% | 382K | $7.1M | +3,390 (+0.9%) | June 30, 2026 |
| 10 | Occam Crest Management L.P. | 1.11% | 357K | $6.6M | −50,000 (−12.3%) | June 30, 2026 |
| 11 | Alyeska Investment Group, L.P. | 0.85% | 275K | $5.1M | +275,000 (0.0%) | June 30, 2026 |
| 12 | State Street Corp | 0.77% | 248K | $4.6M | +81,682 (+49.1%) | June 30, 2026 |
| 13 | Susquehanna International Group, LLP | 0.67% | 217K | $4.0M | +112,000 (+106.4%) | June 30, 2026 |
| 14 | Kalehua Capital Management LLC | 0.62% | 200K | $3.7M | +200,000 (0.0%) | June 30, 2026 |
| 15 | Avidity Partners Management LP | 0.62% | 200K | $3.7M | +200,000 (0.0%) | June 30, 2026 |
| 16 | Northern Trust Corp | 0.45% | 147K | $2.7M | +22,502 (+18.1%) | June 30, 2026 |
| 17 | Vanguard Fiduciary Trust Co | 0.40% | 128K | $2.4M | +12,712 (+11.1%) | June 30, 2026 |
| 18 | Vanguard Portfolio Management, LLC | 0.37% | 118K | $2.2M | +26,143 (+28.4%) | June 30, 2026 |
| 19 | Citadel Advisors Llc | 0.36% | 116K | $2.1M | +37,107 (+47.3%) | June 30, 2026 |
| 20 | Oppenheimer & Co Inc | 0.23% | 74K | $1.4M | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 5.5M shares and 1 cut 50K.
NVCT top mutual fund and ETF holders
18 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.02% | 650K | $12.1M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.66% | 537K | $10.0M | −6,208 (−1.1%) | September 30, 2026 |
| 3 | iShares Russell 2000 Growth ETF | 0.60% | 194K | $3.6M | −245 (−0.1%) | September 30, 2026 |
| 4 | Fidelity Small Cap Index | 0.58% | 187K | $3.5M | +1,758 (+0.9%) | July 31, 2026 |
| 5 | Fidelity Enhanced Small Cap Core ETF | 0.31% | 101K | $1.9M | +210 (+0.2%) | September 30, 2026 |
| 6 | Vanguard Russell 2000 ETF | 0.30% | 98K | $1.8M | +2,418 (+2.5%) | August 31, 2026 |
| 7 | Fidelity Extended Market Index | 0.26% | 84K | $1.6M | −2,468 (−2.8%) | August 31, 2026 |
| 8 | iShares Micro-Cap ETF | 0.20% | 66K | $1.2M | −454 (−0.7%) | September 30, 2026 |
| 9 | iShares Core S&P Total US Stock Mkt ETF | 0.15% | 49K | $916,217 | +40 (+0.1%) | September 30, 2026 |
| 10 | Schwab Small Cap Index | 0.13% | 42K | $772,514 | — | August 31, 2026 |
| 11 | iShares Russell 2000 Small-Cap Idx Instl | 0.10% | 34K | $628,103 | — | August 31, 2026 |
| 12 | Fidelity Total Market Index | 0.10% | 32K | $603,998 | — | August 31, 2026 |
| 13 | Fidelity Series Total Market Index | 0.08% | 27K | $503,372 | — | August 31, 2026 |
| 14 | Nuveen Small Cap Blend Idx R6 | 0.07% | 23K | $421,736 | — | August 31, 2026 |
| 15 | Goldman Sachs ActiveBeta® US SmCp Eq ETF | 0.07% | 22K | $405,499 | — | September 30, 2026 |
| 16 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.07% | 21K | $395,827 | +1,024 (+5.1%) | August 31, 2026 |
| 17 | Vanguard Russell 2000 Growth ETF | 0.06% | 18K | $343,412 | +90 (+0.5%) | August 31, 2026 |
| 18 | EQ/2000 Managed Volatility IB | 0.06% | 18K | $342,370 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NVCT insider transactions
latest 12| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-05 | Juan Sanchez | Buy | $5.79 | 13,000 | $75,270 |
| 2025-11-05 | Matthew L Kaplan | Buy | $5.84 | 11,000 | $64,240 |
| 2025-11-05 | Ron Bentsur | Buy | $5.72 | 5,000 | $28,600 |
| 2025-10-27 | Marlio Charles Mosseri | Buy | $6.28 | 72,836 | $457,410 |
| 2025-10-24 | Marlio Charles Mosseri | Buy | $6.15 | 35,034 | $215,459 |
| 2025-10-23 | Marlio Charles Mosseri | Buy | $6.06 | 46,900 | $284,214 |
| 2025-06-20 | Marlio Charles Mosseri | Buy | $7.99 | 5,603 | $44,768 |
| 2025-06-18 | Marlio Charles Mosseri | Buy | $8.05 | 28,043 | $225,746 |
| 2025-06-17 | Marlio Charles Mosseri | Buy | $8.11 | 5,399 | $43,786 |
| 2025-05-12 | Marlio Charles Mosseri | Buy | $8.11 | 21,167 | $171,664 |
| 2025-05-08 | Marlio Charles Mosseri | Buy | $8.65 | 2,650 | $22,922 |
| 2025-05-06 | Marlio Charles Mosseri | Buy | $8.59 | 12,444 | $106,894 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NVCT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NVCT
Institutional investors own 33.6% of Nuvectis Pharma's shares and insiders 34.43%. The largest holder is TANG CAPITAL MANAGEMENT LLC with 4.80% of the shares (1.6M), as of June 30, 2026. Among the top 20 institutions, 18 added shares and 1 reduced their stake in the latest filings. Short interest is 11.62% of the float, or 12.29 days of average trading volume. The share count rose 445.3% since 2020.
Related: NVCT analyst forecast, NVCT key metrics. See the NVCT stock overview for the latest quote and news.
NVCT ownership FAQ
Who owns the most Nuvectis Pharma stock?
The largest shareholders of Nuvectis Pharma are TANG CAPITAL MANAGEMENT LLC (4.80%), BlackRock Inc (3.10%), Perceptive Advisors LLC (3.10%), Soleus Capital Management, L.P. (3.10%), Vanguard Capital Management, LLC (2.70%).
What percentage of Nuvectis Pharma is owned by institutions?
Institutions hold 33.6% of Nuvectis Pharma's shares outstanding; insiders hold 34.43%.
Which funds own Nuvectis Pharma?
The largest fund holders of Nuvectis Pharma are Vanguard MStar Total Stk Mkt Idx Invest (2.02%), iShares Russell 2000 ETF (1.66%), iShares Russell 2000 Growth ETF (0.60%), Fidelity Small Cap Index (0.58%), Fidelity Enhanced Small Cap Core ETF (0.31%).
What is Nuvectis Pharma's short interest?
2.5M shares of Nuvectis Pharma were sold short, 11.62% of the float; at the average daily volume it would take 12.29 days to cover.
Are insiders buying or selling Nuvectis Pharma?
Of the latest 12 reported insider transactions in Nuvectis Pharma (since May 6, 2025), 12 were purchases and 0 were sales.
How many shares of Nuvectis Pharma are outstanding?
Nuvectis Pharma has 32.6M shares outstanding, of which 21.2M are in the public float.